These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2561853)

  • 1. Cation requirement for GTP regulation of [125I]b-endorphin binding to Mu and sigma opioid receptors.
    Selley DE; Bidlack JM
    NIDA Res Monogr; 1989; 95():537-8. PubMed ID: 2561853
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
    Bidlack JM; O'Malley WE; Schulz R
    Mol Pharmacol; 1988 Feb; 33(2):170-7. PubMed ID: 2828912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-endorphin binding to naloxone-insensitive sites on a human mononuclear cell line (U937): effects of cations and guanosine triphosphate.
    Shahabi NA; Peterson PK; Sharp B
    Endocrinology; 1990 Jun; 126(6):3006-15. PubMed ID: 2161744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain.
    Nock B; Giordano AL; Moore BW; Cicero TJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):349-59. PubMed ID: 8380865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity crosslinking of 125I-human beta-endorphin to cell lines possessing either mu or delta type opioid binding sites.
    Keren O; Gioannini TL; Hiller JM; Simon EJ
    NIDA Res Monogr; 1986; 75():89-92. PubMed ID: 2829014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanine nucleotide regulation of [125I]beta-endorphin binding to rat brain membranes: monovalent cation requirement.
    Selley DE; Tyler CB; Bidlack JM
    J Neurochem; 1988 Jun; 50(6):1844-50. PubMed ID: 2967350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for G-protein-coupled epsilon receptor in the brain of triple opioid receptor knockout mouse.
    Contet C; Matifas A; Kieffer BL
    Eur J Pharmacol; 2004 May; 492(2-3):131-6. PubMed ID: 15178356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linking of [125I]beta-endorphin to mu-opioid receptors during development.
    McLean S; Rothman RB; Chuang DM; Rice KC; Spain JW; Coscia CJ; Roth BL
    Brain Res Dev Brain Res; 1989 Feb; 45(2):283-9. PubMed ID: 2540924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic exercise on beta-endorphin receptor levels in rats.
    Houghten RA; Pratt SM; Young EA; Brown H; Spann DR
    NIDA Res Monogr; 1986; 75():505-8. PubMed ID: 2828998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
    Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB
    Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo receptor binding of opioid drugs at the mu site.
    Rosenbaum JS; Holford NH; Sadée W
    J Pharmacol Exp Ther; 1985 Jun; 233(3):735-40. PubMed ID: 2989495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor.
    Bidlack JM
    NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors.
    Oktem HA; Apaydin S
    Neurobiology (Bp); 1998; 6(3):323-32. PubMed ID: 9778651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A kinetic model of the interaction of stable GTP analogs with a system of opioid receptors].
    Skliankina OA; Kurochkin IN; Keldysh PL; Zaĭtsev SV; Varfolomeev SD
    Biokhimiia; 1988 Feb; 53(2):205-13. PubMed ID: 2835995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL; Zarr GD; Brown SR; Cox BM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide VF-associated satiety involves mu and kappa but not delta subtypes of opioid receptors in chicks.
    Cline MA; Sliwa LN
    Neurosci Lett; 2009 May; 455(3):195-8. PubMed ID: 19429120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.